Search
Standard BioTools Inc
LABAdd to Watchlist
0.989USD
+0.004+0.44%
Close 05/18, 16:00（ET）Quotes delayed by 15 min
386.11MMarket Cap
4.95P/E TTM
More Details of Standard BioTools Inc Company
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Standard BioTools Inc Info
Ticker SymbolLAB
Company nameStandard BioTools Inc
IPO dateFeb 10, 2011
CEOEgholm (Michael)
Number of employees818
Security typeOrdinary Share
Fiscal year-endFeb 10
Address2 Tower Place
CitySOUTH SAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94080
Phone16502666000
Websitehttps://www.standardbio.com/
Ticker SymbolLAB
IPO dateFeb 10, 2011
CEOEgholm (Michael)
Company Executives of Standard BioTools Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
283.53K
-12.23%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
123.57K
-27.06%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
283.53K
-12.23%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
123.57K
-27.06%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Consumables
36.25M
42.48%
Instruments
25.41M
29.78%
Services and other revenue
23.67M
27.74%
By RegionUSD
Name
Revenue
Proportion
Europe & Middle East & Africa (EMEA)
35.99M
42.17%
United States
28.40M
33.28%
China
10.90M
12.77%
Asia Pacific excluding China
7.88M
9.24%
Americas excluding United States
2.16M
2.53%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
36.25M
42.48%
Instruments
25.41M
29.78%
Services and other revenue
23.67M
27.74%
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
22.74%
Viking Global Investors LP
15.02%
BlackRock Institutional Trust Company, N.A.
5.77%
MAK Capital One, LLC
4.94%
Vanguard Capital Management, LLC
3.28%
Other
48.23%
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
22.74%
Viking Global Investors LP
15.02%
BlackRock Institutional Trust Company, N.A.
5.77%
MAK Capital One, LLC
4.94%
Vanguard Capital Management, LLC
3.28%
Other
48.23%
Shareholder Types
Shareholders
Proportion
Hedge Fund
33.98%
Investment Advisor/Hedge Fund
26.18%
Investment Advisor
19.46%
Individual Investor
1.50%
Research Firm
0.64%
Venture Capital
0.62%
Bank and Trust
0.26%
Pension Fund
0.16%
Family Office
0.01%
Other
17.20%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
342
317.36M
81.30%
+773.51K
2025Q4
332
297.38M
77.33%
-28.48M
2025Q3
324
277.96M
72.29%
-27.47M
2025Q2
337
283.64M
74.68%
-28.24M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Casdin Capital, LLC
88.78M
22.76%
+350.00K
+0.40%
Dec 31, 2025
Viking Global Investors LP
58.65M
15.04%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
22.54M
5.78%
+726.65K
+3.33%
Dec 31, 2025
MAK Capital One, LLC
19.29M
4.94%
+3.36M
+21.07%
Dec 31, 2025
Long Focus Capital Management LLC
12.68M
3.25%
+1.32M
+11.58%
Dec 31, 2025
Geode Capital Management, L.L.C.
7.42M
1.9%
-48.22K
-0.65%
Dec 31, 2025
Morgan Stanley Investment Management Inc. (US)
7.23M
1.85%
+1.59M
+28.15%
Dec 31, 2025
State Street Investment Management (US)
6.48M
1.66%
+80.12K
+1.25%
Dec 31, 2025
Hollow Brook Wealth Management, LLC
5.55M
1.42%
-222.36K
-3.85%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.51%
ARK Genomic Revolution ETF
0.33%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Fidelity MSCI Health Care Index ETF
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.51%
ARK Genomic Revolution ETF
Proportion0.33%
iShares Micro-Cap ETF
Proportion0.07%
iShares Biotechnology ETF
Proportion0.04%
iShares Russell 2000 Value ETF
Proportion0.03%
ProShares Hedge Replication ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.02%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Fidelity MSCI Health Care Index ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
